SILVER SPRING, Md., May 04, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the three months ended March 31, 2021. Recent Highlights Recorded […]
Other News
HeartFlow and MedAxiom Announce Collaboration to Improve Care Delivery for Patients with Coronary Artery Disease
REDWOOD CITY, Calif. & NEPTUNE BEACH, Fla.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, and MedAxiom, an American College of Cardiology (ACC) company whose mission is to transform cardiovascular care and improve heart health, announced today a collaboration to improve cardiovascular care for patients with coronary artery disease (CAD). The […]
Verve Therapeutics Appoints Industry Leader Sheila Mikhail to its Board of Directors
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Verve Therapeutics, a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Sheila Mikhail, J.D., MBA, chief executive officer and co-founder of Asklepios BioPharmaceutical, Inc. (AskBio), a subsidiary of Bayer AG, has joined the company’s board of […]
The Feasibility of 12-Lead Computational Analysis in Patients after COVID-19 Infection, using Vektor Medical’s vMap™, presented at Taiwan Heart Rhythm Society (THRS) 2021 Cutting-Edge Care for Heart Rhythm
vMap™ was presented as a technology that was able to provide arrhythmia insights for patients following COVID-19 infection, beyond those available from a standard 12-lead ECG CARLSBAD, Calif.–(BUSINESS WIRE)–Vektor Medical, Inc. announced that a single-center study conducted at the University of California San Diego reports that use of vMap™ (computational 12-lead ECG analysis) […]
Robocath successfully completes first robotic coronary angioplasties in Belgium
Rouen, France, May 4, 2021 – Robocath, a company that designs, develops and commercializes cardiovascular robotic platforms for the treatment of vascular diseases, today announces the successful completion of first five robotic coronary angioplasties in Belgium. The Percutaneous Coronary Interventions (PCI) were performed on April 8 and 13 by Prof. Stefan Verheye, […]
Micro Medical Solutions Receives FDA Breakthrough Device Designation for MicroStent Vascular Stent
Breakthrough Designation Helps Advance Treatment Options, Targeting a Significant Unmet Need in the Treatment of CLTI. WILMINGTON, Mass., May 4, 2021 /PRNewswire/ — Micro Medical Solutions (MMS), an emerging leader in the treatment of CLTI, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its […]
Biobeat’s AI-Powered Remote Patient Monitoring Platform Receives A Full CE Mark
Remote Patient Monitoring Platform Provides Continuous Vital Sign Measurement and Patient Deterioration Identification Capabilities In Hospital and Home Settings PETAH TIKVA, Israel , May 4, 2021 /PRNewswire/ — Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today that its full AI-powered wearable remote patient monitoring platform has received a […]
American Society for Preventive Cardiology to Partner with Vindico Medical Education for CE Educational Symposium: Saving the Hearts of Women with Prevention
JACKSONVILLE, Fla., May 4, 2021 /PRNewswire/ — The American Society for Preventive Cardiology (ASPC) is thrilled to partner with Vindico Medical Education on an educational symposium: Saving the Hearts of Women with Prevention during the ASPC 2021 Virtual Summit on CVD Prevention: Protecting the Heart of One and All. This initiative is an important addition to […]
Semler Reports First Quarter 2021 Financial Results
2021 Q1 HIGHLIGHTS compared to the corresponding period of 2020: – Revenues were $13.2 million, an increase of 40% – Pre-tax net income of $6.0 million, an increase of $2.5 million, or 74%, compared to $3.5 million – Net income was $4.9 million, or $0.73 per basic share and $0.60 […]
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
Westport, CT, May 04, 2021 (GLOBE NEWSWIRE) — The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians have conducted over 800 arrhythmia patient cases to date Currently conducting patient cases in 9 medical centers […]



